VR Logo

Ajanta Pharma: Board to consider Buy-back of equity shares


With reference to the earlier letter dated October 23 2020 informing about the Board Meeting of the Company scheduled to be held on November 03 2020 to consider inter-alia the unaudited consolidated and financial results for the quarter and half year ended September 30 2020 and interim dividend.

Ajanta Pharma Ltd has now informed BSE that at the aforesaid Board Meeting the Board of Directors will also consider a proposal for buy-back of the Equity Shares of the Company including matters related / incidental thereto (?Buyback?) and any other matter as the Board of Directors of the Company may decide during the course of the meeting.

Click here to view PDF